Mehta RS - Search Results

1

Clinical characteristics and biomarkers of breast cancer associated with choline concentration measured by 1H MRS.

Chen JH, Mehta RS, Baek HM, Nie K, Liu H, Lin MQ, Yu HJ, Nalcioglu O, Su MY. Chen JH, et al. Among authors: mehta rs. NMR Biomed. 2011 Apr;24(3):316-24. doi: 10.1002/nbm.1595. Epub 2010 Sep 22. NMR Biomed. 2011. PMID: 20862660 Free PMC article.

2

Measurement of volumetric and vascular changes with dynamic contrast enhanced MRI for cancer therapy monitoring.

Su MY, Yu H, Chiou JY, Wang J, Nalcioglu O, Fruehauf JP, Mehta RS, Baick CH. Su MY, et al. Among authors: mehta rs. Technol Cancer Res Treat. 2002 Dec;1(6):479-88. doi: 10.1177/153303460200100608. Technol Cancer Res Treat. 2002. PMID: 12625775 Free article.

3

Coregistration of dynamic contrast enhanced MRI and broadband diffuse optical spectroscopy for characterizing breast cancer.

Hsiang D, Shah N, Yu H, Su MY, Cerussi A, Butler J, Baick C, Mehta R, Nalcioglu O, Tromberg B. Hsiang D, et al. Technol Cancer Res Treat. 2005 Oct;4(5):549-58. doi: 10.1177/153303460500400508. Technol Cancer Res Treat. 2005. PMID: 16173825 Free article.

4

Quantification of choline-containing compounds in malignant breast tumors by 1H MR spectroscopy using water as an internal reference at 1.5 T.

Baik HM, Su MY, Yu H, Mehta R, Nalcioglu O. Baik HM, et al. MAGMA. 2006 May;19(2):96-104. doi: 10.1007/s10334-006-0032-4. Epub 2006 May 9. MAGMA. 2006. PMID: 16779565

5

Comparison of choline and pharmacokinetic parameters in breast cancer measured by MR spectroscopic imaging and dynamic contrast enhanced MRI.

Su MY, Baik HM, Yu HJ, Chen JH, Mehta RS, Nalcioglu O. Su MY, et al. Among authors: mehta rs. Technol Cancer Res Treat. 2006 Aug;5(4):401-10. Technol Cancer Res Treat. 2006. PMID: 16866570

6

Pathological complete response in triple negative poorly differentiated invasive ductal breast carcinoma detected during pregnancy.

Agrawal G, Chen JH, Baick CH, Chen AE, Mehta RS, Nalcioglu O, Su MY. Agrawal G, et al. Among authors: mehta rs. J Clin Oncol. 2007 Jun 20;25(18):2618-20. doi: 10.1200/JCO.2007.11.3084. J Clin Oncol. 2007. PMID: 17577043 No abstract available.

7

MRI measurements of tumor size and pharmacokinetic parameters as early predictors of response in breast cancer patients undergoing neoadjuvant anthracycline chemotherapy.

Yu HJ, Chen JH, Mehta RS, Nalcioglu O, Su MY. Yu HJ, et al. Among authors: mehta rs. J Magn Reson Imaging. 2007 Sep;26(3):615-23. doi: 10.1002/jmri.21060. J Magn Reson Imaging. 2007. PMID: 17729334

8

MRI features of breast cancer: a correlation study with HER-2 receptor.

Agrawal G, Chen JH, Baek HM, Hsiang D, Mehta RS, Nalcioglu O, Su MY. Agrawal G, et al. Among authors: mehta rs. Ann Oncol. 2007 Nov;18(11):1903-4. doi: 10.1093/annonc/mdm477. Ann Oncol. 2007. PMID: 17993631 Free article. No abstract available.

9

MRI evaluation of pathologically complete response and residual tumors in breast cancer after neoadjuvant chemotherapy.

Chen JH, Feig B, Agrawal G, Yu H, Carpenter PM, Mehta RS, Nalcioglu O, Su MY. Chen JH, et al. Among authors: mehta rs. Cancer. 2008 Jan 1;112(1):17-26. doi: 10.1002/cncr.23130. Cancer. 2008. PMID: 18000804 Free article. Clinical Trial.

10

Pathological axillary lymph node status in HER-2 receptor positive and negative breast cancers.

Chen JH, Agrawal G, Carpenter P, Mehta RS, Nalcioglu O, Su MY. Chen JH, et al. Among authors: mehta rs. Ann Surg Oncol. 2008 Mar;15(3):941-2. doi: 10.1245/s10434-007-9677-0. Epub 2007 Nov 15. Ann Surg Oncol. 2008. PMID: 18004624 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

328 results

Search Page

Filters